HOME >> MEDICINE >> NEWS
A fundamentally new approach to improving cancer chemotherapy

A new strategy for getting anti-cancer drugs to kill cancer cells, without causing serious harm to normal cells in the body, is reported in the current [June] issue of ACS Chemical Biology, a monthly peer-reviewed journal of the American Chemical Society.

The approach, tested in laboratory experiments with several existing anti-cancer drugs, could offer substantial benefits for cancer patients, according to Jeffrey P. Krise, Ph.D. Krise led a group of pharmaceutical and medicinal chemists at the University of Kansas at Lawrence who did the research.

The new approach would allow anticancer drugs to accumulate in both normal and malignant cells. The drugs, however, would be tweaked by giving them "basic" chemical properties. In chemistry, "basic" means an alkaline substance like baking soda or laundry detergent, which has properties opposite those of acidic substances.

Normal cells simply isolate anti-cancer drugs with basic properties, greatly reducing the toxic effects. Cancer cells, in contrast, have an impaired ability to isolate basic substances, and get hit with a full blast of toxicity.

"It could allow cancer patients to tolerate higher and more effective doses of chemotherapy before normal cells are damaged to an extent that causes serious side effects and cessation of therapy," Krise said. "The approach is completely different from previous attempts that were designed to deliver drugs only to cancer cells and not normal cells."

"The results of our studies should lead to the development of rationally designed molecules that are more selective and produce fewer side effects," Krise explained. "Importantly, this technology can also be used to modify existing drugs and increase their selectivity."

Krise's report describes a number of existing anti-cancer drugs that have basic properties, and notes that the new findings may provide the first explanation of why these drugs are so effective.

"There is ob
'"/>

Contact: Michael Bernstein
m_bernstein@acs.org
202-872-4400
American Chemical Society
5-Jun-2006


Page: 1 2

Related medicine news :

1. Patient-centered approach can backfire
2. Report calls for new directions, innovative approaches in testing chemicals for toxicity to humans
3. Clinical review -- A psychological approach to the management of irritable bowel syndrome
4. Rosiglitazone -- Seeking a balanced approach to avoid panic among patients
5. Treatment of kidney condition requires an individualized approach
6. Mayo Clinic study finds heart transplant patients benefit from new approach to immunosuppression
7. Penn study on lung-infecting bacterial enzyme suggests new approach to cystic fibrosis treatment
8. Combined imaging approach may provide better identification of difficult-to-diagnose brain clots
9. AHA statement recommends doctors change approach
10. Penn addiction researcher presents talk on promising approaches in the treatment of drug addiction
11. New data supports a non-invasive approach to routine prenatal genetic testing

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: fundamentally new approach improving cancer chemotherapy

(Date:4/21/2015)... 2015 Carinsurancesavings.biz has released a new blog ... surveillance and explaining the impact on a uto insurance ... and supervised may be eligible for advantageous auto insurance discounts. ... simple and efficient way. This will also help them get ... simple way. , Finding low cost coverage is no longer ...
(Date:4/21/2015)... 2015 Optimity Advisors ( Optimity), ... firm that helps clients in complex industries navigate ... the Association of Community Affiliated Plans ... represents 58 local, not-for-profit, community-affiliated Safety Net Health ... people primarily enrolled in public or state-sponsored coverage ...
(Date:4/21/2015)... CO (PRWEB) April 21, 2015 ... Management , a new knowledge management solution that ... and publishing of policies and procedures. With Quark ... create reusable content that is easy to save, ... is susceptible to risk and compliance issues. Examples ...
(Date:4/21/2015)... When a bandage sticks to an injury ... to solve this problem two inventors from Festus, Mo., ... bandage helps a cut, burn, abrasion or wound heal ... exposure. The bandage is easy to use, versatile and ... submitted to the St. Louis office of InventHelp. It ...
(Date:4/21/2015)... Ill. (PRWEB) April 21, 2015 The ... the late cosmetic dermatologist Fredric S. Brandt, M.D., by ... Dr. Brandt, an ASDS member since 1982, died earlier ... The funds are designed to provide opportunities for ASDS ... field of cosmetic dermatology that Dr. Brandt held so ...
Breaking Medicine News(10 mins):Health News:Auto Insurance Quotes Offer Excellent Security for A Car 2Health News:Optimity Advisors Named Preferred Vendor by the Association of Community Affiliated Plans (ACAP) 2Health News:Quark Software Inc. Introduces Procedure Management Solution for Global 2000 2Health News:Quark Software Inc. Introduces Procedure Management Solution for Global 2000 3Health News:ASDS honors the legacy of Dr. Fredric Brandt 2Health News:ASDS honors the legacy of Dr. Fredric Brandt 3Health News:ASDS honors the legacy of Dr. Fredric Brandt 4
(Date:4/21/2015)... 21, 2015 Asterias Biotherapeutics, Inc. (NYSE MKT: ... of regenerative medicine, today announced that the abstract describing ... from the Phase 2 clinical trial of the Company,s ... selected for an oral presentation at the 2015 American ... held in Chicago, Illinois May ...
(Date:4/20/2015)... 2015  Following is the daily "Profile America" feature ... MEDICINE Profile America — ... insulin —became available for general use this month in ... from diabetes. Insulin is a hormone produced by the ... in the human body. It was first isolated the ...
(Date:4/20/2015)... Ireland , April 20, 2015 ... that Charles M. Mayr , Chief Communications ... due to health reasons.  In conjunction with Mayr,s ... will assume the role of Chief Communications Officer, ... Kelly served as Senior Vice President, Chief Communications ...
Breaking Medicine Technology:Asterias Biotherapeutics Announces Phase 2 Clinical Data on Autologous Telomerase-based Dendritic Cell Cancer Vaccine AST-VAC1 Selected for Oral Presentation at the 2015 ASCO Annual Meeting 2Asterias Biotherapeutics Announces Phase 2 Clinical Data on Autologous Telomerase-based Dendritic Cell Cancer Vaccine AST-VAC1 Selected for Oral Presentation at the 2015 ASCO Annual Meeting 3U.S. Census Bureau Daily Feature for April 21 2Actavis Announces Retirement of Charles M. Mayr 2Actavis Announces Retirement of Charles M. Mayr 3
Cached News: